PROGNOSTIC INDICATORS IN DETERMINATION OF PHEOCHROMOCYTOMA

确定嗜铬细胞瘤的预后指标

• 批准号: 3863949
• 负责人: CHARLES S HOLLANDER
• 金额: --
• 依托单位: NEW YORK UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3863949
• 关键词: clinical trials; clonidine; human subject; neoplasm /cancer diagnosis; pheochromocytoma; prognosis; thyroid neoplasm; vasopressins

Although a small percentage of patients with pheochromocytomas have multiple endocrine neoplasia, patients with medullary thyroid carcinoma are often normotensive and asymptomatic. This study proposes that administering the clonidine suppression test and the phentolamine adrenergic-blocking vasopressin test will unearth many patients with pheochromocytomas.

虽然一小部分嗜铬细胞瘤患者 多发性内分泌瘤，甲状腺髓样癌患者是 通常血压正常且无症状。本研究建议， 可乐定抑制试验和酚妥拉明肾上腺素能阻断试验 加压素试验能发现许多嗜铬细胞瘤病人。